Enanta Pharmaceuticals Inc (ENTA) stock saw a decline, ending the day at $5.75 which represents a decrease of $-0.10 or -1.71% from the prior close of $5.85. The stock opened at $6 and touched a low ...

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) has earned a consensus rating of “Moderate Buy” from the five ...

NASDAQ:ENTA opened at $6.01 on Monday. Enanta Pharmaceuticals, Inc. has a 12-month low of $5.70 and a 12-month high of $17.80. The firm has a market cap of $127.38 million, a PE ratio of -1.10 and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Senores Pharmaceuticals Share Price Live Updates: Senores Pharmaceuticals shares made their Dalal Street debut today after high demand for its initial public offering (IPO). Senores ...

Of these four IPOs, the listing date of Senores Pharmaceuticals IPO, Ventive Hospitality IPO, and Carraro India IPO have been fixed on 30 December 2024, i.e. Monday next week. Unimech Aerospace's ...

Jefferies analyst Dennis Ding initiated coverage of Rhythm Pharmaceuticals (RYTM) with a Buy rating and $80 price target Discover the latest stocks recommended by top Wall Street analysts ...

Wedbush analyst Yun Zhong initiated coverage of Rocket Pharmaceuticals (RCKT) with an Outperform rating and $32 price target Discover the latest stocks recommended by top Wall Street analysts ...

MONTREAL and CHARLOTTE, N.C., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today announced that President and CEO, Joe Oliveto, and Chief Commercial Officer ...